These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3249926)

  • 1. [Serum antibodies against brain tissue in patients with multiple sclerosis].
    Rysková O; Vejbora O
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1988; 31(4):407-11. PubMed ID: 3249926
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum antibodies against brain tissue in multiple sclerosis patients: a frequent phenomenon in chronic progressive, but not relapsing disease course].
    Henneberg A; Mayle DM; Pfau JU; Hartmann P; Elsner U; Kornhuber HH
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):593-6. PubMed ID: 7856267
    [No Abstract]   [Full Text] [Related]  

  • 3. [Research on autoantibodies in multiple sclerosis].
    Szabó S; Lukács E; Lapohos E; Malatinszky EG; Wagner RC; Becuş T
    Stud Cercet Neurol; 1968; 13(1):19-27. PubMed ID: 5665111
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinico-immunologic correlations in disseminated sclerosis].
    Zavalishin IA; Khondkarian OA; Nevskaia OM; Pivovarova AI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):164-7. PubMed ID: 6608842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunologic differentiation of brain antigens in multiple sclerosis].
    Panov AG; Shamreĭ RK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(2):161-70. PubMed ID: 636708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of the immunofluorescence and immunodiffusion methods for the detection of anti-brain antibodies in the sera of patients with central nervous system diseases].
    Gannuszkina IW; Weinrauder H; Zirnowa IG
    Neuropatol Pol; 1983; 21(2):183-90. PubMed ID: 6415514
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-neurofilament antibodies in slow infections of the nervous system].
    Zavalishin IA; Pogodina VV; Roikhel' VM; Fokina GI; Niiazbekova AS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(2):11-6. PubMed ID: 3376639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum antibodies to cytoplasmic antigens of the human brain in patients with multiple sclerosis and amyotropic lateral sclerosis].
    Khondkarian OA; Maksudov GA; Ignatov SA; Burbaeva GSh; Domashneva IV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(2):198-201. PubMed ID: 842237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A longitudinal study of immunological parameters in multiple sclerosis (author's transl)].
    Simon J; Mar P; Neu I; Kamm S; Schrader A
    Nervenarzt; 1980 Mar; 51(3):176-82. PubMed ID: 7453878
    [No Abstract]   [Full Text] [Related]  

  • 10. Organ-specific IgM autoantibodies to liver, heart and brain in man: generalized occurrence and possible functional significance in normal individuals, and studies in patients with multiple sclerosis.
    Daar AS; Fabre JW
    Clin Exp Immunol; 1981 Jul; 45(1):37-47. PubMed ID: 7030539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of immunologic reactions after brain injury. II. Antibodies against brain tissue lipids after blunt head injury in man.
    Procházka M; Voltnerová M; Stefan J
    Int Surg; 1971 May; 55(5):322-6. PubMed ID: 5088567
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple sclerosis immune complexes: an analysis of component antigens and antibodies.
    Coyle PK; Procyk-Dougherty Z
    Ann Neurol; 1984 Dec; 16(6):660-7. PubMed ID: 6098217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gluten sensitivity in multiple sclerosis: experimental myth or clinical truth?
    Shor DB; Barzilai O; Ram M; Izhaky D; Porat-Katz BS; Chapman J; Blank M; Anaya JM; Shoenfeld Y
    Ann N Y Acad Sci; 2009 Sep; 1173():343-9. PubMed ID: 19758171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multiple sclerosis: advances in its pathogenesis].
    Godoy J; Court J
    Rev Med Chil; 1982 Jun; 110(6):581-4. PubMed ID: 6761822
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of neuroallergy in the pathogenesis of multiple sclerosis].
    Vilkov GA; Martirosian VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):206-9. PubMed ID: 3885657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
    Lily O; Palace J; Vincent A
    Brain; 2004 Feb; 127(Pt 2):269-79. PubMed ID: 14662514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Virus neutralizing and antibrain antibodies in multiple sclerosis and multiple encephalomyelitis].
    Zinchenko AP; Shamreĭ RK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(4):541-8. PubMed ID: 4301248
    [No Abstract]   [Full Text] [Related]  

  • 18. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
    Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myelinotoxic activity of the serum in multiple sclerosis patients].
    Matveeva TS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):528-31. PubMed ID: 3716701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gliotoxic properties of multiple sclerosis and polyradiculoneuritis serum detectable in brain organ culture].
    Smirnov IuK; Ravkina LI; Goriunova AG; Veĭn AM; Khomak VIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):181-3. PubMed ID: 7041493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.